An international study published in 'The Lancet Diabetes & Endocrinology' shows that a higher 7.2 mg dose of semaglutide is safe and significantly boosts weight loss in obese adults, with and without type 2 diabetes. Participants saw greater reductions in weight, waist size, blood sugar, and cholesterol, with manageable side effects.